Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 September 2025 | Story Anthony Mthembu | Photo Lunga Luthuli
Martin Nyaka
Martin Nyaka, Second Deputy Secretary General of the South African Union of Students (SAUS).

Martin Nyaka, Secretary General of the 2024-2025 Institutional Student Representative Council (ISRC) and Policy and Transformation Officer (CSRC) on the Bloemfontein Campus of the University of the Free State (UFS), has been elected as Second Deputy Secretary General (DSG) of the South African Union of Students (SAUS)

Nyaka was elected during the first leg of the SAUS conference, held in Gqeberha from 10-13 July 2025. His election is historic, as this is the first time the union has appointed a second DSG. In his new role, he joins the National Executive Council (NEC) alongside the SAUS President, Deputy President, Secretary General, Treasurer-General, and the First DSG.  

“It is a great honour for me to have represented the University of the Free State at this important platform, and I remain deeply grateful for the support and assistance I received from the institution throughout this journey,” said Nyaka. He will serve in this role until the next election in 2028. 

 

Anticipated impact

Nyaka explained that his decision to stand for election was influenced by challenges he and his SRC colleagues encountered when addressing certain student-related issues. He noted that some concerns, such as those linked with the National Student Financial Aid Scheme (NSFAS), can only be resolved at a national level. 

“This position places us in a better position to assist students and to ensure that our students are funded,” he said.  

In addition to his role as Second DSG, Nyaka also chairs the SAUS Monitoring and Evaluation portfolio, which oversees several sub-committees within the organisation.  

 

Lessons from leadership 

As his SRC term draws to a close, Nyaka reflected on the lessons he will carry into this new role. 

“Previously, as student leaders our mindset was very radical, and if ever things would not go our way, we would take to the streets,” he explained. “However, over this last term, the SRC resolved matters and reached agreements with management without protest. An important lesson I take with me is that radicalism is not always the answer. In an organisation like SAUS, we need to sit down and have discussions with stakeholders when there is a deadlock.”

Nyaka emphasised that what excites him most about the opportunity is the chance to work alongside student-leaders from across the country who are equally committed to making a meaningful impact.  

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept